NSGC 2023 - Ambry Genetics

Wednesday

October 18

Poster Session 5:30 PM – 7:00 PM (2 Posters)

Thursday

October 19

Poster Session 5:30 PM – 7:00 PM (2 Posters)
Oral Presentations 11:00 AM – 12:30 PM

Friday

October 20

Oral Presentations 7:45 AM – 8:30 AM

64b0818c3d83f_Chicago_IL

Wednesday, October 18

5:30 PM – 7:00 PM

2 Posters

Session

PCAN62

Always better when we’re together: A novel, collaborative multi-stakeholder coalition enhances national guidelines for hereditary cancer testing and detection

Poster

Abstract

Ann Marie Miller, Emily K. Dalton, Fred Struve, Jessica Grzybowski, Kelli Conlan, Kristen Postula, Lauren Sferrazza, Lisa Schlager, Rebecca Johnson, Robert Pilarski, Robin Dubin, Shelly Cummings

Session

PASD31

If we build it patients will come: A healthcare system's approach to improve identification of at-risk individuals, increase genetic counseling referrals, and build patient management using a digital tool and EMR

Abstract

Poster

Chelsea Menke, Courtney Rice, Haley Keller, Heather Fecteau, Shannon Kiernan

Thursday, October 19

5:30 PM – 7:00 PM

2 Posters

Session

PGGT225

Splicing up the diagnosis: Using targeted RNA studies to reclassify exome sequencing variants

Abstract

Poster

Heather Zimmermann, Jessica Gage, Jessica Grzybowski, Jesus Ramirez Castano, Meghan Towne

Session

PASD15

Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program accurately identifies high risk individuals

Poster

Abstract

Carrie Horton, Carrie Milliard, Deepika Nathan, Devon Lamb Thrush, Haley Keller, Heather Fecteau, Lukas Lyon, Robert Pilarski, Sarah Siddiqui, Shannon Kieran

Thursday, October 19

11:00 AM – 12:30 PM

3 Presentations

Session

Educational Breakout Session

Not all actionable variants in BRCA1 and BRCA2 are created equal: Challenges of classifying and interpreting reduced-penetrance variants

Marcy Richardson, PhD; Tuya Pal (Vanderbilt), Erin Mundt (Myriad), Matthew Lebo (LMMM), Yeni Rodriguez Sanabria

Session

Platform

Addressing equity in exome sequencing: Proactive reanalysis helps to reduce racial, ethnic, and ancestral disparities

Abstract

Andrew Giles

Session

Platform

Identification of high-risk hereditary cancer syndrome patients in a primary care cohort using a patient-facing risk stratification tool

Abstract

Jenny Geurts, Med College of WI

Friday, October 20

7:45 AM – 8:30 AM

1 Presentation

Session

Breakfast Symposia

Reassessed and revealed: Patient and genetic counselor experience with proactive reanalysis

Meagan Farmer, MS, MBA, LCGC; Meghan Towne, MS, CGC; LGC Kelly Minks, MS, CGC